Nelfinavir-induced urticaria and successful desensitization.
Demoly
P
P
Centre Hospitalier Universitaire, Maladies Respiratoires, Hôpital Arnaud de Villeneuve, Montpellier Cedex 5, France.
Messaad
D
D
Trylesinski
A
A
Faucherre
V
V
Fabre
J
J
Reynes
J
J
Delmas
C
C
Dohin
E
E
Godard
P
P
Bousquet
J
J
D000328:Adult; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000628:therapy; D015658:HIV Infections / Q000628:therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D019888:Nelfinavir / Q000009:adverse effects* / Q000627:therapeutic use; D014581:Urticaria / Q000139:chemically induced* / Q000628:therapy*
D017320:HIV Protease Inhibitors; D019888:Nelfinavir